C3 Drives Inflammatory Skin Carcinogenesis Independently of C5.

The Journal of Investigative Dermatology
William D JacksonMarina Botto

Abstract

Nonmelanoma skin cancer such as cutaneous squamous cell carcinoma (cSCC) is the most common form of cancer and can occur as a consequence of DNA damage to the epithelium by UVR or chemical carcinogens. There is growing evidence that the complement system is involved in cancer immune surveillance; however, its role in cSCC remains unclear. Here, we show that complement genes are expressed in tissue from patients with cSCC, and C3 activation fragments are present in cSCC biopsies, indicating complement activation. Using a range of complement-deficient mice in a two-stage mouse model of chemically-induced cSCC, where a subclinical dose of 7,12-dimethylbenz[a]anthracene causes oncogenic mutations in epithelial cells and 12-O-tetradecanoylphorbol-13-acetate promotes the outgrowth of these cells, we found that C3-deficient mice displayed a significantly reduced tumor burden, whereas an opposite phenotype was observed in mice lacking C5aR1, C5aR2, and C3a receptor. In addition, in mice unable to form the membrane attack complex, the tumor progression was unaltered. C3 deficiency did not affect the cancer response to 7,12-dimethylbenz[a]anthracene treatment alone but reduced the epidermal hyperplasia during 12-O-tetradecanoylphorbol-13...Continue Reading

References

May 1, 1993·The Journal of Clinical Investigation·J A HalperinA Nicholson-Weller
Jun 29, 2004·Molecular Immunology·Osnat Bohana-KashtanZvi Fishelson
Dec 1, 2004·Immunobiology·Deepak Bhole, Gregory L Stahl
Feb 22, 2005·Neoplasia : an International Journal for Oncology Research·Karin E de VisserLisa M Coussens
Oct 6, 2005·The Journal of Biological Chemistry·Norma P GerardCraig Gerard
Sep 22, 2007·Journal of Leukocyte Biology·Jean M DaleyJorge E Albina
May 6, 2008·Nature Medicine·Daniel RittirschPeter A Ward
Jul 25, 2008·Nature·Alberto MantovaniFrances Balkwill
Sep 30, 2008·Nature Immunology·Maciej M MarkiewskiJohn D Lambris
Dec 23, 2008·Molecular Immunology·Anne-Marie ScolaPeter N Monk
May 30, 2009·Molecular Immunology·Andreas KlosJörg Köhl
May 27, 2010·British Journal of Cancer·P WorkmanUNKNOWN Committee of the National Cancer Research Institute
Jun 20, 2012·Archives of Dermatology·Jo Leonardi-BeeFiona Bath-Hextall
Jun 30, 2012·Nature Methods·Johannes SchindelinAlbert Cardona
Aug 24, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Lacey GunnJun Yan
Oct 3, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Leticia CorralesRuben Pio
Dec 12, 2012·Neoplasia : an International Journal for Oncology Research·Selene Nunez-CruzNathalie Scholler
Jan 19, 2013·Science·Lisa M CoussensA Karolina Palucka
Aug 14, 2013·The Journal of Investigative Dermatology·Pilvi M RiihiläVeli-Matti Kähäri
Nov 15, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Maria AntsiferovaSabine Werner
Apr 30, 2014·Immunology and Cell Biology·Daniel E CrokerMatthew A Cooper
Sep 4, 2014·The Journal of Investigative Dermatology·Pilvi RiihiläVeli-Matti Kähäri
Oct 5, 2014·The Lancet Oncology·Connie I DiakosStephen J Clarke
May 10, 2015·Immunobiology·B Paul Morgan
Jun 16, 2015·Frontiers in Immunology·Nicolas S MerleLubka T Roumenina
Jun 18, 2015·Frontiers in Immunology·Nicolas S MerleLubka T Roumenina
Nov 24, 2016·The Journal of Investigative Dermatology·Chiara GiacomassiMarina Botto
Mar 23, 2017·The American Journal of Pathology·Pilvi RiihiläVeli-Matti Kähäri
Apr 12, 2017·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Felix PoppelaarsMarc A Seelen
Sep 15, 2017·American Journal of Physiology. Renal Physiology·Ina V MartinSusanne N Weber

❮ Previous
Next ❯

Citations

Oct 30, 2020·Antibodies·Margot RevelLubka T Roumenina

❮ Previous
Next ❯

Software Mentioned

ImageJ
NanoString
GraphPad
GraphPad Prism

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.